Peng, Liyuan http://orcid.org/0000-0002-0813-1449
Song, Ziping
Zhao, Chengcheng
Abuduwufuer, Kudusi
Wang, Yanwen
Wen, Zheng
Ni, Li
Li, Chenze
Yu, Ying
Zhu, Yi
Jiang, Hualiang
Shen, Jinshan
Jiang, Xiangrui
Chen, Chen
Zhang, Xu
Wang, Dao Wen
Clinical trials referenced in this document:
Documents that mention this clinical trial
Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics
https://doi.org/10.1007/s43657-022-00069-8
Funding for this research was provided by:
National Natural Science Foundation of China (81790624, 81900342, 81790621)
Article History
Received: 4 November 2021
Revised: 25 July 2022
Accepted: 28 July 2022
First Online: 27 October 2022
Change Date: 29 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s43657-022-00088-5
Declarations
:
: The authors have no conflicts of interest to declare that are relevant to the content of this article.
: The study protocols were approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
: Written informed consent was obtained from all the participants.
: All the participants approved to publish.